Monday, June 15, 2026

Middle East Tensions: Safeguarding Citizens Amidst the Iran-Israel Conflict

U.S. intensifies response to Iran conflict, ensuring citizen safety and military readiness amid escalating tensions in the Middle East.

Hypertension Hits Young Adults Hard — But They’re Not Getting Treated

Nearly 10 million die from hypertension yearly. Awareness is low among young adults, increasing health risks and complications.

Revolutionary Biodegradable Stents for Pets: Meet the First Four Approved by South Korea

M.I. Tech has become the first South Korean company to receive approval for biodegradable stents for pets, addressing traditional stent complications.

Tag: metabolic diseases

Celltrion Moves CT-G32 Into Final Preclinical Stage as Global Obesity Trial Preparation Accelerates

Celltrion advances CT-G32, a next-gen obesity treatment, targeting multiple pathways to enhance weight loss while preserving muscle mass.

Frequent Delivery Meals and Abdominal Obesity Emerging as Key Drivers of Early Hypertension Risk

Increased use of delivery apps and late-night eating habits are raising hypertension and metabolic disease risks among young adults.

JW Pharmaceuticals Secures Exclusive Rights for Innovative GLP-1 Drug Vopaglutide in South Korea

JW Pharmaceutical secures exclusive rights for Vopaglutide, a promising treatment for diabetes and obesity, with significant milestone payments.

New Obesity Drug Shows Big Promise — and It’s Not from Eli Lilly or Novo

Metsera leads emerging obesity treatments with promising drug MET-233i, showing significant weight loss in trials, amid rising competition.

Top News

- Our Sponsors Ad -

Follow us